Abstract
Variceal hemorrhage is one the most harrowing situations encountered by GI fellows in training. It will be encountered frequently and emergently. Management of acute variceal hemorrhage demands sound endoscopic technique, prompt resuscitation, and medical therapy with antibiotics and somatostatin analogues. Despite advances in techniques and algorithms, the mortality rate and re-bleeding rate associated with variceal hemorrhage remain high. The Child-Pugh class, size of the varix, and endoscopic presence of high-risk stigmata determine the choice between non-selective beta blocker (NSBB) and endoscopic variceal ligation in the primary prevention of esophageal hemorrhage, while secondary prevention requires both. Proper dosing and tolerance of NSBB is challenging but can preclude further endoscopic surveillance. Gastric varices are defined by their location. They are less common, but more challenging. Glue injection and TIPS are currently the prominent tools used in both acute hemorrhage and secondary prevention, while primary prevention is typically avoided.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology. 1981;80(4):800–9.
Carbonell N, Pauwels A, Serfaty L, et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40:652–9.
Pagliaro L, D’Amico G, Pasta L, Politi F, Vizzini G, Traina M, et al. Portal hypertension in cirrhosis: Natural history. In: Bosch J, Groszmann RJ, editors. Portal Hypertension. Pathophysiology and treatment. Oxford, UK: Blackwell Scientific; 1994. p. 72–92.
Groszmann RJ, Bosch J, Grace N, Conn HO, Garcia-Tsao G, Navasa M, et al. Hemodynamic events in a prospective randomized trial of propranolol vs placebo in the prevention of the first variceal hemorrhage. Gastroenterology. 1990;99:1401–7.
Moitinho E, Escorsell A, Bandi JC, Salmeron JM, Garcia-Pagan JC, Rodes J, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology. 1999;117:626–31.
Monescillo A, Martinez-Lagares F, Ruiz del Arbol L, Sierra A, Guevara C, Jimenez E, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology. 2004;40:793–801.
Merli M, Nicolini G, Angeloni S, Rinaldi V, De Santis A, Merkel C, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol. 2003;38:266–72.
Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet. 2003;361:952–4.
D’Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis. 1999;19:475–505.
Riggio O, Angeloni S, Nicolini G, et al. Endoscopic screening for esophageal varices in cirrhotic patients. Hepatology. 2002;35:501–2.
Groszmann RJ, Garcia-Tsao G, Bosch J, et al. for the Portal hypertension collaborative group. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005;353:2254–61.
Abraldes JG, Albillos A, Banares R, et al. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial. Gastroenterology. 2009;136:1651–8.
Serste T, Melot C, Francoz C, et al. Deleterious effects of beta blockers on survival in patients with cirrhosis and refractory ascites. Hepatology. 2010;52:1017–22.
Mandorfer M, et al. Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis. Gastroenterology. 146(7):1680–90.
Bolognesi M, Balducci G, Garcia-Tsao G, Gatta A, Gines P, Merli M, et al. Complications in the medical treatment of portal hypertension. Portal hypertension III. Proceedings of the third Baveno international consensus workshop on definitions, methodology and therapeutic strategies. Oxford, UK: Blackwell Science; 2001. p. 180–203.
Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368:11–21.
Bernard B, Grange JD, Khac EN, et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology. 1999;29:1655–61.
Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila FI, Soares-Weiser K, Uribe M. Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2010;(9):CD002907. Review. PubMed PMID: 20824832.
Wells M, Chande N, Adams P, et al. Meta-analysis: vasoactive medications for the management of acute variceal bleeds. Aliment Pharmacol Ther. 2012;35:1267–78.
Higashi H, Kitano S, Hashizume M, Yamaga H, Sugimachi K. A prospective randomized trial of schedules for sclerosing esophageal varices. 1 versus 2 week intervals. Hepatogastroenterology 1989;36:337–40.
Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med. 1995;123:280–7.
Petrasch F, Grothaus J, Mossner J, et al. Differences in bleeding behavior after endoscopic band ligation: a retrospective analysis. BMC Gastroenterol. 2010;10:5.
Young MF, Sanowski RA, Rasche R. Comparison and characterization of ulcerations induced by endoscopic ligation of esophageal varices versus endoscopic sclerotherapy. Gastrointest Endosc. 1993;39:119–22.
Shaheen NJ, Stuart E, Schmitz SM, et al. Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial. Hepatology. 2005;41:588–94.
Saeed ZA, Stiegmann GV, Ramirez FC, et al. Endoscopic variceal ligation is superior to combined ligation and sclerotherapy for esophageal varices: a multicenter prospective randomized trial. Hepatology. 1997;25:71–4.
Garcia-Tsao G, Bosch J. Varices and variceal hemorrhage in cirrhosis: a new view of an old problem. Clin Gastoenterol Hepatol. 2015;13:2109–17.
Avgerinos A, Armonis A. Balloon tamponade technique and efficacy in variceal haemorrhage. Scand J Gastroenterol Suppl. 1994;207:11–6.
Dechene A, El Fouly AH, Bechmann LP, Jochum C, Saner FH, Gerken G, et al. Acute management of refractory variceal bleeding in liver cirrhosis by self-expanding metal stents. Digestion. 2012;85(3):185–91.
Holster IL, Kuipers EJ, van Buuren HR, Spaander MC, Tjwa ET. Self-expandable metal stents as definitive treatment for esophageal variceal bleeding. Endoscopy. 2013;45(6):485–8.
Hsu YC, Chung CS, Tseng CH, Lin TL, Liou JM, Wu MS, et al. Delayed endoscopy as a risk factor for in-hospital mortality in cirrhotic patients with acute variceal hemorrhage. J Gastroenterol Hepatol. 2009;24(7):1294–9.
McCormick PA, Dick R, Panagou EB, et al. Emergency transjugular intrahepatic portasystemic stent shunting as salvage treatment for uncontrolled variceal bleeding. Br J Surg. 1994;81:1324–7.
D’Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis. 1999;19:475–505.
Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet. 2003;361:952–4.
de la Pena J, Brullet E, Sanchez-Hernandez E, et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology. 2005;41:572–8.
Escorsell A, Banares R, Garcia-Pagan JC, Gilabert R, Moitinho E, Piqueras B, et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology. 2002;35:385–92.
Garcia-Pagan JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362:2370–9.
Garcia-Pagan JC, Di Pascoli M, Caca K, et al. Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol. 2013;58:45–50.
Gluud LL, Langholz E, Krag A. Meta-analysis: isosorbidemononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices. Aliment Pharmacol Ther. 2010;32:859–71.
Sarin SK, Lahoti D, Saxena SP, et al. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology. 1992;16:1343–9.
Kim T, Shijo H, Kokawa H, et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology. 1997;25:307–12.
Cheng LF, Wang ZQ, Li CZ, et al. Low incidence of complications from endoscopic gastric variceal obturation with butyl cyanoacrylate. Clin Gastroenterol Hepatol. 2010;8:760–6.
Wang YM, Cheng LF, Li N, et al. Study of glue extrusion after endoscopic N-butyl-2-cyanoacrylate injection on gastric variceal bleeding. World J Gastroenterol. 2009;15:4945–51.
Garcia-Pagan JC, et al. Management of Gastric Varices. Clinical Gastroenterology and Hepatology. 2014;12:919–28.
Teres J, Cecilia A, Bordas JM, et al. Esophageal tamponade for bleeding varices: controlled trial between the Sengstaken-Blakemore tube and the Linton-Nachlas tube. Gastroenterology. 1978;75:566–9.
Chau TN, Patch D, Chan YW, et al. “Salvage” transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology. 1998;114:981–7.
Mishra SR, Chander SB, Kumar A, et al. Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial. Gut. 2010;59:729–35.
Hung HH, Chang CJ, Hou MC, et al. Efficacy of non-selective beta-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding: a randomized controlled trial. J Hepatol. 2012;56:1025–32.
Mahadeva S, Bellamy MC, Kessel D, et al. Cost effectiveness of N-butyl-2-cyanoacrylate (Histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am J Gastroenterol. 2003;98:2688–93.
Lo GH, Liang HL, Chen WC, et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy. 2007;39:679–85.
Procaccini NJ, Al-Osaimi AM, Northup P, et al. Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center US analysis. Gastrointest Endosc. 2009;70:881–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Control of active bleeding from esophageal varices (MP4 39079 kb)
Obliteration of gastric varices using cyanoacrylate glue (MP4 52891 kb)
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Tau, J.A., Qureshi, W.A. (2017). Variceal Upper GI Bleeding. In: Adler, D. (eds) Upper Endoscopy for GI Fellows. Springer, Cham. https://doi.org/10.1007/978-3-319-49041-0_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-49041-0_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-49039-7
Online ISBN: 978-3-319-49041-0
eBook Packages: MedicineMedicine (R0)